hydration effects glp-1 receptor agonist therapy 2025 Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Application of nutrition interventions with
Description
R.HolscherC.GaultV
The possibility of providing preventive regimen in multi system pathologies is a significant use of the GLP-1RA in improving disease outcomes and preventing morbidity
Still, careful monitoring of thyroid function and medication requirements remains critical, especially in the context of significant weight loss
Samanc B, Samanc Y, Tzn E, et al
Graphical Abstract Similar content being viewed by others Introduction Obesity is an escalating global health issue
